← Leaderboards
Alex G Waterson
Vanderbilt University Medical Center
$938,173
Attributed
$2,134,893
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $373.3K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,134,893 · 2
By mechanism
R01$1,795,080 · 1
P30$339,813 · 1
Top collaborators
- Deborah Lannigan-Macara5 shared
- Gary Allen Sulikowski5 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Mingzhi Zhang$10,481,956
- Italo Biaggioni$17,539,936
- Laura Carpin Kennedy$817,315
- Fabian Maximilian Bock$477,132
- Eman Gohar$2,153,540
Others in their field
Other Emerging Leaders on “Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$56,843,703
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
Research focus
ResistanceMalignant NeoplasmsLeadPropertyStructurePharmaceutical ChemistryComplexIn VivoNovel TherapeuticsProgramsStructure-Activity RelationshipTumorPharmaceutical PreparationsBiochemicalBiologicalCellsInsightIn VitroDrug KineticsAntiestrogen TherapyEndocrineBaseCardiovascular InfectionAutomobile Driving
Grant awards (6)
Chemical Synthesis and High-Throughput Analytics Shared Resource$339,813
P30 · FY2025 · CA · contact PI
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$352,773
R01 · FY2022 · CA
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$359,982
R01 · FY2021 · CA
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$359,985
R01 · FY2020 · CA
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$349,083
R01 · FY2019 · CA
RSK2 in Estrogen Receptor Positive (ER+) Breast Cancer$373,257
R01 · FY2018 · CA